Log in

NASDAQ:TBPHTheravance Biopharma SEC Filings & 10K Form

$22.84
+0.67 (+3.02 %)
(As of 04/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$21.48
Now: $22.84
$23.13
50-Day Range
$17.84
MA: $23.84
$26.12
52-Week Range
$15.18
Now: $22.84
$31.54
Volume201,420 shs
Average Volume439,963 shs
Market Capitalization$1.44 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.46

SEC Filings

Theravance Biopharma (NASDAQ:TBPH) SEC Filings

DateFilerForm TypeView
03/24/2020
3:19 PM
Theravance Biopharma (Filer)
Form DEF 14A
03/09/2020
3:31 PM
BlackRock Inc. (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
03/04/2020
3:55 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2020
6:16 PM
Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:15 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:13 PM
Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:12 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:11 PM
PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:10 PM
PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:08 PM
Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:07 PM
HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
6:05 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
5:02 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2020
3:21 PM
Theravance Biopharma (Filer)
Form 424B5
02/06/2020
8:23 AM
BlackRock Inc. (Filed by)
Theravance Biopharma (Subject)
Form SC 13G/A
02/05/2020
6:07 PM
Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
6:06 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
6:05 PM
Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
6:04 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
6:02 PM
PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
6:00 PM
PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:58 PM
Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:57 PM
HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2020
5:55 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2020
8:49 AM
Theravance Biopharma (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
01/13/2020
7:15 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
4:20 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
3:51 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
5:09 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2019
5:02 PM
Theravance Biopharma (Filer)
Form S-3ASR
11/22/2019
5:28 PM
Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:26 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:25 PM
Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:24 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:23 PM
PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:22 PM
PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:20 PM
HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2019
5:18 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2019
2:01 PM
Theravance Biopharma (Subject)
Woodford Investment Management Ltd (Filed by)
Form SC 13G/A
11/08/2019
5:17 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2019
3:45 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2019
7:09 AM
Link Fund Solutions Ltd (Filed by)
Theravance Biopharma (Subject)
Form SC 13G
09/30/2019
7:00 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2019
6:10 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2019
6:06 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/22/2019
5:08 PM
Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:07 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:06 PM
Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:05 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:03 PM
PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:02 PM
PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:01 PM
HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
5:00 PM
HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2019
4:58 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
10:48 AM
Theravance Biopharma (Filer)
Form CT ORDER
08/05/2019
3:31 PM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
6:10 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
5:05 PM
Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2019
8:15 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
7:16 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
4:47 PM
Hindman Andrew A. (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/04/2019
8:22 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
5:19 PM
Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:17 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:15 PM
Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:13 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:11 PM
PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:09 PM
PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:07 PM
HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:05 PM
HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2019
5:03 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2019
5:02 PM
O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2019
8:02 AM
Theravance Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/10/2019
5:11 AM
Theravance Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2019
3:52 PM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2019
5:44 PM
Molineaux Susan (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:36 PM
Theravance Biopharma (Issuer)
YOUNG WILLIAM D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:34 PM
Theravance Biopharma (Issuer)
WHITESIDES GEORGE M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:32 PM
RINGROSE PETER S (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:28 PM
O'Connor Donal (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:23 PM
MITCHELL DEAN J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:21 PM
MALKIEL BURTON G (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:17 PM
Gunderson Robert V JR (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:14 PM
BROSHY ERAN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2019
5:11 PM
Smaldone Alsup Laurie (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/01/2019
7:30 AM
Theravance Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2019
9:49 AM
GLAXOSMITHKLINE PLC (Filed by)
Theravance Biopharma (Subject)
Form SC 13D/A
03/20/2019
4:18 PM
Theravance Biopharma (Filer)
Form DEF 14A
03/06/2019
6:20 PM
HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:27 PM
Theravance Biopharma (Issuer)
WORBOYS PHILIP D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:25 PM
Theravance Biopharma (Issuer)
Winningham Rick E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:23 PM
SULIMAN SHEHNAAZ (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:22 PM
Shafer Bradford J (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:20 PM
SABESAN VIJAY (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:18 PM
PITZER KENNETH R (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:16 PM
PASQUALONE FRANK (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:15 PM
HEGDE SHARATHCHANDRA S (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:13 PM
HAUMANN BRETT K (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2019
5:11 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
5:15 PM
BRADY ANN (Reporting)
Theravance Biopharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
This page was last updated on 4/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel